Eurobio Scientific SA
PAR:ALERS
Eurobio Scientific SA
PAR:ALERS
Price:
23.85
EUR
-0.21%
Market Cap:
€244.5m
Relative Value
The Relative Value of one
ALERS
stock under the Base Case scenario is
42.2
EUR.
Compared to the current market price of 23.85 EUR,
Eurobio Scientific SA
is
Undervalued by 43%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALERS
Relative Value
Base Case
42.2
EUR
Undervaluation 43%
Multiples Across Competitors
ALERS Competitors Multiples
Eurobio Scientific SA Competitors
Eurobio Scientific SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Eurobio Scientific SA
PAR:ALERS
|
240.1m EUR | 1.5 | 101.7 | 7.3 | 18.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 746 422.5 | -160 391.7 | -165 649.1 | -163 758.9 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
398.8B USD | 6.7 | 169.8 | 16.4 | 23.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
185.3B USD | 5.2 | 26.5 | 18.9 | 18.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
177.3B USD | 6.1 | 21.9 | 14.8 | 14.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120B USD | 10.2 | 32.6 | 24 | 25.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 087.6 | -532.7 | -682 | -663.8 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.5B USD | 5.5 | 17.6 | 14.9 | 17 | |
| AU |
|
CSL Ltd
ASX:CSL
|
86.7B AUD | 3.8 | 19.7 | 9.1 | 11.3 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.5B EUR | 14.3 | 33.6 | 68 | 69.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.7 | -78.2 | -70.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
